Tech Company Financing Transactions

Saladax Biomedical Funding Round

Excel Venture Management, Life Sciences Greenhouse of Central Pennsylvania and private investors invested in a $8.4 million Series C funding round for Saladax Biomedical. The round was announced on 3/5/2010.

Transaction Overview

Company Name
Saladax Biomedical
Announced On
3/5/2010
Transaction Type
Venture Equity
Amount
$8,400,000
Round
Series C
Investors

Excel Venture Management (Lead Investor) (Enrico Petrillo)

Life Sciences Greenhouse of Central Pennsylvania (Kevin Harter)

Proceeds Purpose
The funding will be used to accelerate product development and expand clinical support of Saladax's MYCARE� line of diagnostic tests, which measure blood levels of cancer and Central Nervous System (CNS) disorder drugs, providing physicians with guidance to personalize patient dosing for optimal efficacy.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
116 Research Dr.
Bethlehem, PA 18015
USA
Phone
(610) 419-6731
Website
www.saladax.com
Email Address
[email protected]
Overview
Saladax Biomedical is pioneering the development of novel, fast andinexpensive immunoassays that will enable routine blood level monitoringof anti-cancer drugs to become the standard of care in treating cancer patients.
Profile
Saladax Biomedical LinkedIn Company Profile
Social Media
Saladax Biomedical Company Twitter Account
Company News
Saladax Biomedical News
Facebook
Saladax Biomedical on Facebook
YouTube
Saladax Biomedical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Salvatore Salamone
  Salvatore Salamone LinkedIn Profile  Salvatore Salamone Twitter Account  Salvatore Salamone News  Salvatore Salamone on Facebook
VP - Bus. Development
DeWayne Davenport
  DeWayne Davenport LinkedIn Profile  DeWayne Davenport Twitter Account  DeWayne Davenport News  DeWayne Davenport on Facebook
VP - R & D
Irina Baburina
  Irina Baburina LinkedIn Profile  Irina Baburina Twitter Account  Irina Baburina News  Irina Baburina on Facebook
VP - Regulatory Affairs
Sue Werner
  Sue Werner LinkedIn Profile  Sue Werner Twitter Account  Sue Werner News  Sue Werner on Facebook

 

 

Browse more venture capital transactions:

Prev: 3/5/2010: Kineto Wireless venture capital transaction
Next: 3/5/2010: PayNearMe venture capital transaction

 

Share this article

 

Where The Data Comes From

Our team works diligently to document funding rounds that are announced publicly. All VC database entries reported here come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.